5-[[4-[2-(5-乙基-2-吡啶基)-乙氧基]苯基]亚甲基]-2,4-噻唑烷二酮
中文别名:
吡咯列酮烯;5-[[4-[2-(5-乙基-2-吡啶基)-乙氧基]苯基]亚甲基]-2,4-噻唑烷二酮;吡格列酮杂质B;盐酸吡格列酮烯;吡格列酮杂质B (EP);吡格列酮烯(5-[[4-[2-(5-乙基-2-吡啶基)-乙氧基]-苯基]甲烯基]-2,4-噻唑烷酮);吡格列酮EP杂质B;吡咯列酮烯(吡咯列酮杂质B)
英文名称:
5-[4-[2-(5-ETHYL-PURIDIN-2-YL-ETHOXY)BENZYLDENE]THIAZOLIDINE-2,4-DIONE
英文别名:
(E)-5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzylidene)thiazolidine-2,4-dione;5-[4-[2-(5-ETHYL-PURIDIN-2-YL-ETHOXY)BENZYLDENE]THIAZOLIDINE-2,4-DIONE;5-{{4-[2-(5-ETHYL-2-PYRIDINYL)ETHOXY]PHENYL}METHYLENE}-2,4-THIAZOLIDIONE;5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy];5-(4-(2-(5-ETHYL-2-PYRIDINYDETHOXY)BENZYLIDENE)-2,4-THIAZOL;5-{4-[2-(5-ethyl-2-pyridinyl)ethoxyl]benzyldene}-2,4-thiazolidinedione;5-{4-[2-(5-Ethyl-pyridin-2-yl)-ethoxy]-;5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]-Methylene]-2,4-thiazolidinedione
(Pioglitazone IMpurity)
InChI:
InChI=1/C19H18N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,11-12H,2,9-10H2,1H3,(H,21,22,23)/b17-11+
密度:
1.301±0.06 g/cm3(Predicted)
产品用途:
5-[[4-[2-(5-乙基-2-吡啶基)-乙氧基]苯基]亚甲基]-2,4-噻唑烷二酮用于药物吡格列酮的合成制备中。